Speakers: Shannon Foster, DO

Speaker Disclosures: Statements, opinions and results of studies contained in the program are those of the presenters and authors and do not reflect the policy or position of the Board of Regents of the University of Oklahoma (“OU”) nor does OU provide any warranty as to their accuracy or reliability.

Professional Practice Gap: 1. According to the latest evidence, some practitioners fail to properly diagnose insomnia disorder before prescribing sedative hypnotics. 2. Practitioners may not know the specific uses for each sedative hypnotic with regards to initiation and/or maintenance insomnia. 3. Practitioners may not know the specific components of cognitive behavioral therapy and how they compliment each other in the treatment of primary insomnia disorder.

Learning Objectives:

Upon completion of this session, participants will improve their competence and performance by being able to:

1. Define primary insomnia disorder and be able to distinguish common differential diagnoses.

2. Summarize the current clinical practice guidelines for the management of primary insomnia disorder.

3. Recognize recent trends in sedative use, sleep medication prescriptions, and over the counter sleep aides.

4. Distinguish between the available FDA approved sleep aides by mechanism of action and recommended uses.

5. Summarize the components of cognitive behavioral therapy for insomnia treatment.